Article
A comprehensive approach to evaluate genetic abnormalities in multiple myeloma using optical genome mapping
3 May 2024
Abstract excerpt
Multiple myeloma (MM) is a plasma cell neoplasm (PCN) [ 1 ]. Sensitive and accurate identification of genetic abnormalities is critical for patient risk stratification and therapeutic decision-making as well as understanding pathogenesis. Recurring genetic abnormalities include structural variants (SVs), such as rearrangements involving IGH and MYC genes; copy number variants (CNVs), such as 1q+, del(17p),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
